ask="6.93"
ask_size="200"
average_daily_volume="856539"
bid="5.61"
bid_size="100"
book_value="0.05"
change="-0.09"
change_from_200_day_moving_average="1.90"
change_from_50_day_moving_average="0.40"
change_from_52_week_high="-3.91"
change_From_52_week_low="4.70"
change_in_percent="-1.40%"
close="6.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.91"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="46336000"
high="6.52"
high_52_weeks="10.24"
last_trade_date="12/30/2016"
last_trade_price="6.33"
last_trade_size="78259"
last_trade_time="4:00pm"
low="6.28"
low_52_weeks="1.63"
market_capitalization="466.89M"
moving_average_200_day="4.43"
moving_average_50_day="5.93"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.08"
open="6.47"
pe_ratio="N/A"
peg_ratio="-0.35"
percent_change_from_200_day_moving_average="+42.83%"
percent_change_from_50_day_moving_average="+6.74%"
percent_change_from_52_week_high="-38.18%"
percent_change_from_52_week_low="+288.34%"
previous_close="6.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="118.89"
price_per_sales="21.55"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.22"
stock_exchange="NMS"
symbol="BCRX"
volume="623596"
weeks_range_52="1.63 - 10.24"
